168 related articles for article (PubMed ID: 15176680)
1. Impact of sputum bacteria on airway inflammation and health status in clinical stable COPD.
Banerjee D; Khair OA; Honeybourne D
Eur Respir J; 2004 May; 23(5):685-91. PubMed ID: 15176680
[TBL] [Abstract][Full Text] [Related]
2. The effect of oral clarithromycin on bronchial airway inflammation in moderate-to-severe stable COPD: a randomized controlled trial.
Banerjee D; Honeybourne D; Khair OA
Treat Respir Med; 2004; 3(1):59-65. PubMed ID: 15174894
[TBL] [Abstract][Full Text] [Related]
3. Effect of bronchial colonisation on airway and systemic inflammation in stable COPD.
Marin A; Garcia-Aymerich J; Sauleda J; Belda J; Millares L; García-Núñez M; Serra I; Benet M; Agustí A; Antó JM; Monsó E;
COPD; 2012 Apr; 9(2):121-30. PubMed ID: 22458940
[TBL] [Abstract][Full Text] [Related]
4. COPD is characterized by increased detection of Haemophilus influenzae, Streptococcus pneumoniae and a deficiency of Bacillus species.
Simpson JL; Baines KJ; Horvat JC; Essilfie AT; Brown AC; Tooze M; McDonald VM; Gibson PG; Hansbro PM
Respirology; 2016 May; 21(4):697-704. PubMed ID: 26781464
[TBL] [Abstract][Full Text] [Related]
5. Colour of sputum is a marker for bacterial colonisation in chronic obstructive pulmonary disease.
Miravitlles M; Marín A; Monsó E; Vilà S; de la Roza C; Hervás R; Esquinas C; García M; Millares L; Morera J; Torres A
Respir Res; 2010 May; 11(1):58. PubMed ID: 20470372
[TBL] [Abstract][Full Text] [Related]
6. Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis.
Hill AT; Campbell EJ; Hill SL; Bayley DL; Stockley RA
Am J Med; 2000 Sep; 109(4):288-95. PubMed ID: 10996579
[TBL] [Abstract][Full Text] [Related]
7. Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease.
Sethi S; Maloney J; Grove L; Wrona C; Berenson CS
Am J Respir Crit Care Med; 2006 May; 173(9):991-8. PubMed ID: 16474030
[TBL] [Abstract][Full Text] [Related]
8. Progranulin is a substrate for neutrophil-elastase and proteinase-3 in the airway and its concentration correlates with mediators of airway inflammation in COPD.
Ungurs MJ; Sinden NJ; Stockley RA
Am J Physiol Lung Cell Mol Physiol; 2014 Jan; 306(1):L80-7. PubMed ID: 24186875
[TBL] [Abstract][Full Text] [Related]
9. Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease.
Rosell A; Monsó E; Soler N; Torres F; Angrill J; Riise G; Zalacaín R; Morera J; Torres A
Arch Intern Med; 2005 Apr; 165(8):891-7. PubMed ID: 15851640
[TBL] [Abstract][Full Text] [Related]
10. Association between pathogens detected using quantitative polymerase chain reaction with airway inflammation in COPD at stable state and exacerbations.
Barker BL; Haldar K; Patel H; Pavord ID; Barer MR; Brightling CE; Bafadhel M
Chest; 2015 Jan; 147(1):46-55. PubMed ID: 25103335
[TBL] [Abstract][Full Text] [Related]
11. Patients with chronic obstructive pulmonary disease and chronically colonized with Haemophilus influenzae during stable disease phase have increased airway inflammation.
Tufvesson E; Bjermer L; Ekberg M
Int J Chron Obstruct Pulmon Dis; 2015; 10():881-9. PubMed ID: 26005341
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics and airway inflammation profile of COPD persistent sputum producers.
Khurana S; Ravi A; Sutula J; Milone R; Williamson R; Plumb J; Vestbo J; Singh D
Respir Med; 2014 Dec; 108(12):1761-70. PubMed ID: 25459449
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory thresholds and the species-specific effects of colonising bacteria in stable chronic obstructive pulmonary disease.
Singh R; Mackay AJ; Patel AR; Garcha DS; Kowlessar BS; Brill SE; Donnelly LE; Barnes PJ; Donaldson GC; Wedzicha JA
Respir Res; 2014 Sep; 15(1):114. PubMed ID: 25218165
[TBL] [Abstract][Full Text] [Related]
14. Bacterial load and inflammatory response in sputum of alpha-1 antitrypsin deficiency patients with COPD.
Balbi B; Sangiorgi C; Gnemmi I; Ferrarotti I; Vallese D; Paracchini E; Delle Donne L; Corda L; Baderna P; Corsico A; Carone M; Brun P; Cappello F; Ricciardolo FL; Ruggeri P; Mumby S; Adcock IM; Caramori G; Di Stefano A
Int J Chron Obstruct Pulmon Dis; 2019; 14():1879-1893. PubMed ID: 31686800
[TBL] [Abstract][Full Text] [Related]
15. [Etiology and biomarkers of systemic inflammation in mild to moderate COPD exacerbations].
Saldías PF; Díaz PO; Dreyse DJ; Gaggero BA; Sandoval AC; Lisboa BC
Rev Med Chil; 2012 Jan; 140(1):10-8. PubMed ID: 22552550
[TBL] [Abstract][Full Text] [Related]
16. A two-stage logistic model based on the measurement of pro-inflammatory cytokines in bronchial secretions for assessing bacterial, viral, and non-infectious origin of COPD exacerbations.
Dal Negro RW; Micheletto C; Tognella S; Visconti M; Guerriero M; Sandri MF
COPD; 2005 Mar; 2(1):7-16. PubMed ID: 17136956
[TBL] [Abstract][Full Text] [Related]
17. Sputum microbiology predicts health status in COPD.
Braeken DC; Houben-Wilke S; Smid DE; Rohde GG; Drijkoningen JJ; Wouters EF; Spruit MA; Franssen FM
Int J Chron Obstruct Pulmon Dis; 2016; 11():2741-2748. PubMed ID: 27853361
[TBL] [Abstract][Full Text] [Related]
18. The effect of oral clarithromycin on health status and sputum bacteriology in stable COPD.
Banerjee D; Khair OA; Honeybourne D
Respir Med; 2005 Feb; 99(2):208-15. PubMed ID: 15715188
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the bacterial community in chronic obstructive pulmonary disease sputum samples by denaturing gradient gel electrophoresis and real-time PCR.
Wu D; Hou C; Li Y; Zhao Z; Liu J; Lu X; Shang X; Xin Y
BMC Pulm Med; 2014 Nov; 14():179. PubMed ID: 25403149
[TBL] [Abstract][Full Text] [Related]
20. The effect of azithromycin in adults with stable neutrophilic COPD: a double blind randomised, placebo controlled trial.
Simpson JL; Powell H; Baines KJ; Milne D; Coxson HO; Hansbro PM; Gibson PG
PLoS One; 2014; 9(8):e105609. PubMed ID: 25148049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
